Global Pharmaceutical Microcrystalline Cellulose Market Growth 2025-2031

Publication ID:

LPI06253449

Publication Date:

June 4, 2025

Pages:

109

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Pharmaceutical Microcrystalline Cellulose market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Pharmaceutical Microcrystalline Cellulose is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Pharmaceutical Microcrystalline Cellulose is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Pharmaceutical Microcrystalline Cellulose is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Pharmaceutical Microcrystalline Cellulose players cover International Flavors & Fragrances, JRS Pharma, Shin-Etsu Chemical Co., Ltd., Ashland, Asahi Kasei, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淧harmaceutical Microcrystalline Cellulose Industry Forecast鈥� looks at past sales and reviews total world Pharmaceutical Microcrystalline Cellulose sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Microcrystalline Cellulose sales for 2025 through 2031. With Pharmaceutical Microcrystalline Cellulose sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Microcrystalline Cellulose industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Microcrystalline Cellulose landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Microcrystalline Cellulose portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pharmaceutical Microcrystalline Cellulose market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Microcrystalline Cellulose and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Microcrystalline Cellulose.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Microcrystalline Cellulose market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Particle Size Less Than 50 Microns
Particle Size 50-100 Microns
Particle Size Greater Than 100 Microns
Segmentation by Application:
Sustained Release Preparation
Tablet
Capsule
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
International Flavors & Fragrances
JRS Pharma
Shin-Etsu Chemical Co., Ltd.
Ashland
Asahi Kasei
Mingtai
Huzhou Zhanwang
Sunhere Pharmaceutical Excipients
Shandong HEAD
Lotte Chemicals
Shandong Liaocheng E HUA Pharmaceutical Co., Ltd
Yingkou AODA Pharmaceuticals
Accent Microcell
Qufu TIANLI MEDICAL Supplements
C & J Chemical Industries Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharmaceutical Microcrystalline Cellulose market?
What factors are driving Pharmaceutical Microcrystalline Cellulose market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Microcrystalline Cellulose market opportunities vary by end market size?
How does Pharmaceutical Microcrystalline Cellulose break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Microcrystalline Cellulose Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pharmaceutical Microcrystalline Cellulose by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pharmaceutical Microcrystalline Cellulose by Country/Region, 2020, 2024 & 2031
2.2 Pharmaceutical Microcrystalline Cellulose Segment by Type
2.2.1 Particle Size Less Than 50 Microns
2.2.2 Particle Size 50-100 Microns
2.2.3 Particle Size Greater Than 100 Microns
2.3 Pharmaceutical Microcrystalline Cellulose Sales by Type
2.3.1 Global Pharmaceutical Microcrystalline Cellulose Sales Market Share by Type (2020-2025)
2.3.2 Global Pharmaceutical Microcrystalline Cellulose Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pharmaceutical Microcrystalline Cellulose Sale Price by Type (2020-2025)
2.4 Pharmaceutical Microcrystalline Cellulose Segment by Application
2.4.1 Sustained Release Preparation
2.4.2 Tablet
2.4.3 Capsule
2.5 Pharmaceutical Microcrystalline Cellulose Sales by Application
2.5.1 Global Pharmaceutical Microcrystalline Cellulose Sale Market Share by Application (2020-2025)
2.5.2 Global Pharmaceutical Microcrystalline Cellulose Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pharmaceutical Microcrystalline Cellulose Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Pharmaceutical Microcrystalline Cellulose Breakdown Data by Company
3.1.1 Global Pharmaceutical Microcrystalline Cellulose Annual Sales by Company (2020-2025)
3.1.2 Global Pharmaceutical Microcrystalline Cellulose Sales Market Share by Company (2020-2025)
3.2 Global Pharmaceutical Microcrystalline Cellulose Annual Revenue by Company (2020-2025)
3.2.1 Global Pharmaceutical Microcrystalline Cellulose Revenue by Company (2020-2025)
3.2.2 Global Pharmaceutical Microcrystalline Cellulose Revenue Market Share by Company (2020-2025)
3.3 Global Pharmaceutical Microcrystalline Cellulose Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Microcrystalline Cellulose Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Microcrystalline Cellulose Product Location Distribution
3.4.2 Players Pharmaceutical Microcrystalline Cellulose Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Pharmaceutical Microcrystalline Cellulose by Geographic Region
4.1 World Historic Pharmaceutical Microcrystalline Cellulose Market Size by Geographic Region (2020-2025)
4.1.1 Global Pharmaceutical Microcrystalline Cellulose Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pharmaceutical Microcrystalline Cellulose Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pharmaceutical Microcrystalline Cellulose Market Size by Country/Region (2020-2025)
4.2.1 Global Pharmaceutical Microcrystalline Cellulose Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pharmaceutical Microcrystalline Cellulose Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmaceutical Microcrystalline Cellulose Sales Growth
4.4 APAC Pharmaceutical Microcrystalline Cellulose Sales Growth
4.5 Europe Pharmaceutical Microcrystalline Cellulose Sales Growth
4.6 Middle East & Africa Pharmaceutical Microcrystalline Cellulose Sales Growth
5 Americas
5.1 Americas Pharmaceutical Microcrystalline Cellulose Sales by Country
5.1.1 Americas Pharmaceutical Microcrystalline Cellulose Sales by Country (2020-2025)
5.1.2 Americas Pharmaceutical Microcrystalline Cellulose Revenue by Country (2020-2025)
5.2 Americas Pharmaceutical Microcrystalline Cellulose Sales by Type (2020-2025)
5.3 Americas Pharmaceutical Microcrystalline Cellulose Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Microcrystalline Cellulose Sales by Region
6.1.1 APAC Pharmaceutical Microcrystalline Cellulose Sales by Region (2020-2025)
6.1.2 APAC Pharmaceutical Microcrystalline Cellulose Revenue by Region (2020-2025)
6.2 APAC Pharmaceutical Microcrystalline Cellulose Sales by Type (2020-2025)
6.3 APAC Pharmaceutical Microcrystalline Cellulose Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pharmaceutical Microcrystalline Cellulose by Country
7.1.1 Europe Pharmaceutical Microcrystalline Cellulose Sales by Country (2020-2025)
7.1.2 Europe Pharmaceutical Microcrystalline Cellulose Revenue by Country (2020-2025)
7.2 Europe Pharmaceutical Microcrystalline Cellulose Sales by Type (2020-2025)
7.3 Europe Pharmaceutical Microcrystalline Cellulose Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Microcrystalline Cellulose by Country
8.1.1 Middle East & Africa Pharmaceutical Microcrystalline Cellulose Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pharmaceutical Microcrystalline Cellulose Revenue by Country (2020-2025)
8.2 Middle East & Africa Pharmaceutical Microcrystalline Cellulose Sales by Type (2020-2025)
8.3 Middle East & Africa Pharmaceutical Microcrystalline Cellulose Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Microcrystalline Cellulose
10.3 Manufacturing Process Analysis of Pharmaceutical Microcrystalline Cellulose
10.4 Industry Chain Structure of Pharmaceutical Microcrystalline Cellulose
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Microcrystalline Cellulose Distributors
11.3 Pharmaceutical Microcrystalline Cellulose Customer
12 World Forecast Review for Pharmaceutical Microcrystalline Cellulose by Geographic Region
12.1 Global Pharmaceutical Microcrystalline Cellulose Market Size Forecast by Region
12.1.1 Global Pharmaceutical Microcrystalline Cellulose Forecast by Region (2026-2031)
12.1.2 Global Pharmaceutical Microcrystalline Cellulose Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pharmaceutical Microcrystalline Cellulose Forecast by Type (2026-2031)
12.7 Global Pharmaceutical Microcrystalline Cellulose Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 International Flavors & Fragrances
13.1.1 International Flavors & Fragrances Company Information
13.1.2 International Flavors & Fragrances Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.1.3 International Flavors & Fragrances Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 International Flavors & Fragrances Main Business Overview
13.1.5 International Flavors & Fragrances Latest Developments
13.2 JRS Pharma
13.2.1 JRS Pharma Company Information
13.2.2 JRS Pharma Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.2.3 JRS Pharma Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 JRS Pharma Main Business Overview
13.2.5 JRS Pharma Latest Developments
13.3 Shin-Etsu Chemical Co., Ltd.
13.3.1 Shin-Etsu Chemical Co., Ltd. Company Information
13.3.2 Shin-Etsu Chemical Co., Ltd. Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.3.3 Shin-Etsu Chemical Co., Ltd. Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Shin-Etsu Chemical Co., Ltd. Main Business Overview
13.3.5 Shin-Etsu Chemical Co., Ltd. Latest Developments
13.4 Ashland
13.4.1 Ashland Company Information
13.4.2 Ashland Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.4.3 Ashland Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Ashland Main Business Overview
13.4.5 Ashland Latest Developments
13.5 Asahi Kasei
13.5.1 Asahi Kasei Company Information
13.5.2 Asahi Kasei Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.5.3 Asahi Kasei Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Asahi Kasei Main Business Overview
13.5.5 Asahi Kasei Latest Developments
13.6 Mingtai
13.6.1 Mingtai Company Information
13.6.2 Mingtai Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.6.3 Mingtai Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Mingtai Main Business Overview
13.6.5 Mingtai Latest Developments
13.7 Huzhou Zhanwang
13.7.1 Huzhou Zhanwang Company Information
13.7.2 Huzhou Zhanwang Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.7.3 Huzhou Zhanwang Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Huzhou Zhanwang Main Business Overview
13.7.5 Huzhou Zhanwang Latest Developments
13.8 Sunhere Pharmaceutical Excipients
13.8.1 Sunhere Pharmaceutical Excipients Company Information
13.8.2 Sunhere Pharmaceutical Excipients Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.8.3 Sunhere Pharmaceutical Excipients Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Sunhere Pharmaceutical Excipients Main Business Overview
13.8.5 Sunhere Pharmaceutical Excipients Latest Developments
13.9 Shandong HEAD
13.9.1 Shandong HEAD Company Information
13.9.2 Shandong HEAD Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.9.3 Shandong HEAD Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Shandong HEAD Main Business Overview
13.9.5 Shandong HEAD Latest Developments
13.10 Lotte Chemicals
13.10.1 Lotte Chemicals Company Information
13.10.2 Lotte Chemicals Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.10.3 Lotte Chemicals Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Lotte Chemicals Main Business Overview
13.10.5 Lotte Chemicals Latest Developments
13.11 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd
13.11.1 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Company Information
13.11.2 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.11.3 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Main Business Overview
13.11.5 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Latest Developments
13.12 Yingkou AODA Pharmaceuticals
13.12.1 Yingkou AODA Pharmaceuticals Company Information
13.12.2 Yingkou AODA Pharmaceuticals Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.12.3 Yingkou AODA Pharmaceuticals Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Yingkou AODA Pharmaceuticals Main Business Overview
13.12.5 Yingkou AODA Pharmaceuticals Latest Developments
13.13 Accent Microcell
13.13.1 Accent Microcell Company Information
13.13.2 Accent Microcell Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.13.3 Accent Microcell Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Accent Microcell Main Business Overview
13.13.5 Accent Microcell Latest Developments
13.14 Qufu TIANLI MEDICAL Supplements
13.14.1 Qufu TIANLI MEDICAL Supplements Company Information
13.14.2 Qufu TIANLI MEDICAL Supplements Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.14.3 Qufu TIANLI MEDICAL Supplements Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Qufu TIANLI MEDICAL Supplements Main Business Overview
13.14.5 Qufu TIANLI MEDICAL Supplements Latest Developments
13.15 C & J Chemical Industries Co., Ltd.
13.15.1 C & J Chemical Industries Co., Ltd. Company Information
13.15.2 C & J Chemical Industries Co., Ltd. Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.15.3 C & J Chemical Industries Co., Ltd. Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 C & J Chemical Industries Co., Ltd. Main Business Overview
13.15.5 C & J Chemical Industries Co., Ltd. Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂